z-logo
open-access-imgOpen Access
An Unusual Form of Chronic Myeloproliferative Disorder Aleukemic Basophilic Leukemia
Author(s) -
Lertprasertsuke Nirush,
Tsutsumi Yutaka
Publication year - 1991
Publication title -
acta patholigica japonica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 74
ISSN - 0001-6632
DOI - 10.1111/j.1440-1827.1991.tb03275.x
Subject(s) - pathology , basophilic , medicine , hepatosplenomegaly , bone marrow , eosinophilic , leukemia , leukocytosis , spleen , immunology , disease
A 52‐year‐old Japanese man manifested various clinical signs and symptoms such as vomiting, high fever, dyspnea, cough, sweating, palpitation, eosinophilic leukocytosis and hepatosplenomegaly. These histamine related clinical manifestations showed a dramatic response to steroid therapy. After 10 months of hospitalization, he suddenly succumbed to candidal septicemia at the end of the third cycle of steroid therapy. Autopsy revealed neoplastic proliferation of immature basophils in various internal organs without involvement of the skin. The neoplastic cells, positive immunohistochemically for leukocyte common antigen, possessed lobulated nuclei and weakly metachromatic cytoplasmic granules, predominantly of the basophil type, which exhibited weak naphthol ASD‐chloroacetate esterase activity. Mast cell type granules were also observed ultrastructurally. The neoplastic infiltration was associated with fibrosis in the liver, spleen and bone marrow and with extramedullary hematopoiesis in the liver, spleen, lymph nodes and perihypophyseal tissue. The bone marrow showed uneven and multifocal involvement. Despite the lack of leukemic manifestations and the results of chromosomal analysis, the most suitable diagnosis was aleukemic basophilic leukemia within the category of chronic myeloproliferative disorder. Kinship of this neoplasia to systemic mastocytosis is discussed. Acta Pathol Jpn 41: 73 81, 1991.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here